A carregar...
Nucleolin-Targeting AS1411 Aptamer-Modified Micelle for the Co-Delivery of Doxorubicin and miR-519c to Improve the Therapeutic Efficacy in Hepatocellular Carcinoma Treatment
BACKGROUND: Multidrug resistance (MDR) has emerged to be a major hindrance in cancer therapy, which contributes to the reduced sensitivity of cancer cells toward chemotherapeutic drugs mainly owing to the over-expression of drug efflux transporters. The combination of gene therapy and chemotherapy h...
Na minha lista:
| Publicado no: | Int J Nanomedicine |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8019667/ https://ncbi.nlm.nih.gov/pubmed/33833512 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IJN.S304526 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|